AbCellera Biologics Inc (ABCL)
3.13
+0.10
(+3.30%)
USD |
NASDAQ |
Jan 03, 16:00
3.13
0.00 (0.00%)
After-Hours: 20:00
AbCellera Biologics Market Cap: 924.50M for Jan. 3, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aurinia Pharmaceuticals Inc | 1.223B |
| Edesa Biotech Inc | 6.519M |
| Lexaria Bioscience Corp | 39.97M |
| Xenon Pharmaceuticals Inc | 3.088B |
| ESSA Pharma Inc | 82.56M |
Market Cap Related Metrics
| PS Ratio | 27.83 |
| PEG Ratio | -0.1443 |
| Price to Book Value | 0.8575 |
| Price | 3.13 |
| Earnings Yield | -19.49% |
| PEGY Ratio | -0.1443 |